Learn
Suggested guidances for use of ketamine and esketamine therapy have been published in the American Journal of Psychiatry....
Psychedelic use may help to decrease the risk of hypertension, according to new research....
This week in psychedelic business news sees pharmaceutical giant Merck enter the arena, psilocybin research, and more....
Scientists are closer to unraveling the mystery behind the psilocybin effects and its ability to offer anti-depressive benefits....
Rick Doblin, the founder of MAPS, joined actress Mayim Bialik's podcast Breakdown to discuss MDMA and PTSD research....
The University of Wisconsin is the first in the U.S. to offer a master's degree in development of psychedelic medicine....
Pharmaceutical giant Merck is partnering with psychedelic research company Novamind to test a possible therapy for treatment-resistant depression....
A new survey finds women are more likely to self-treat with psychedelics than men, particularly for issues including depression and...
New psychedelic research underway in Australia will look at the success of treating meth addiction with psilocybin....
Can psilocybin help cure obesity? NeonMind Biosciences is hopeful. The company is researching the benefits of psychedelics for eating disorders....